These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27564430)

  • 1. Deconstructing Designer Drugs.
    Sellers EM
    Clin Pharmacol Ther; 2017 Feb; 101(2):167-169. PubMed ID: 27564430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.
    Helander A; Bäckberg M
    Clin Toxicol (Phila); 2017 Jan; 55(1):1-3. PubMed ID: 27549399
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recreational drugs: the complication's pleasure?].
    Joye F; Donzé N; Frochaux V; Niquille M; Selz Amaudruz F
    Rev Med Suisse; 2013 Aug; 9(394):1454-60. PubMed ID: 24024389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The New Zealand Psychoactive Substances Act (PSA): a policy breakthrough or just a symbolic act?
    Bretteville-Jensen AL
    Addiction; 2014 Oct; 109(10):1590-1. PubMed ID: 25163706
    [No Abstract]   [Full Text] [Related]  

  • 5. Poison in party pills is too much to swallow.
    Cole M
    Nature; 2011 Jun; 474(7351):253. PubMed ID: 21677705
    [No Abstract]   [Full Text] [Related]  

  • 6. BZP-party pills: a review of research on benzylpiperazine as a recreational drug.
    Cohen BM; Butler R
    Int J Drug Policy; 2011 Mar; 22(2):95-101. PubMed ID: 21242080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to commentaries.
    Wilkins C
    Addiction; 2014 Oct; 109(10):1593-4. PubMed ID: 25163708
    [No Abstract]   [Full Text] [Related]  

  • 8. New psychoactive substances: issues about the new approach from New Zealand government.
    von Diemen L
    Addiction; 2014 Oct; 109(10):1588-9. PubMed ID: 25163704
    [No Abstract]   [Full Text] [Related]  

  • 9. New synthetic drugs in addictovigilance.
    Chavant F; Boucher A; Le Boisselier R; Deheul S; Debruyne D
    Therapie; 2015; 70(2):167-89. PubMed ID: 25858573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prohibition is a key driver of the new psychoactive substances (NPS) phenomenon.
    Rolles S; Kushlick D
    Addiction; 2014 Oct; 109(10):1589-90. PubMed ID: 25163705
    [No Abstract]   [Full Text] [Related]  

  • 11. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
    Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illicit drugs of abuse.
    Schulz JE
    Prim Care; 1993 Mar; 20(1):221-30. PubMed ID: 8464943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthetic Drugs - An Overview of Important and Newly Emerging Substances].
    Betzler F; Heinz A; Köhler S
    Fortschr Neurol Psychiatr; 2016 Nov; 84(11):690-698. PubMed ID: 27846654
    [No Abstract]   [Full Text] [Related]  

  • 15. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new danger of synthetic drugs.
    Arnold C
    Lancet; 2013 Jul; 382(9886):15-6. PubMed ID: 23841151
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problem of illegal drugs in Japan].
    Kojima T
    Chudoku Kenkyu; 2007 Oct; 20(4):305-17. PubMed ID: 18044211
    [No Abstract]   [Full Text] [Related]  

  • 18. Designer Drugs 2.0.
    Huestis MA; Tyndale RF
    Clin Pharmacol Ther; 2017 Feb; 101(2):152-157. PubMed ID: 28084644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Designer drugs and anesthesia].
    Nogué S; Monsalve C
    Rev Esp Anestesiol Reanim; 2005 Apr; 52(4):191-2. PubMed ID: 15901023
    [No Abstract]   [Full Text] [Related]  

  • 20. [New psychoactive substances and their prevalence in the Czech Republic].
    Mravčík V; Běláčková V; Grohmannová K; Zábranský T
    Cas Lek Cesk; 2015; 154(5):216-21. PubMed ID: 26612328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.